Thank you very much, Mr. Chair.
Ms. Bard, thank you for your testimony. I particularly appreciated the fact that you reminded us of the importance of the fourth pillar in Canada's National Anti-Drug Strategy: harm reduction.
As my colleague Libby Davies pointed out, before 2007, this was part of the Canadian anti-drug policy. But, as priorities change when a new government arrives, in 2007, one year after the Conservative government took power, the fourth pillar disappeared. I already know your position on harm reduction and its importance in Canada, and I would like to know the position of the other witnesses.
Should harm reduction be reinstated in the Canadian anti-drug strategy?